TrialInternational journal of chronic obstructive pulmonary disease2017

The efficacy of extrafine beclomethasone dipropionate-formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.